Molecular and functional characteristics of proton-coupled folate transporter

Journal of Pharmaceutical Sciences

Volumn 98, Issue 5, 2009, Pages 1608-1616

  Yuasa, Hiroaki ^a   Inoue, Katsuhisa ^a   Hayashi, Yayoi ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b KINJO GAKUIN UNIVERSITY   (Japan)

Author keywords

Active transport; Drug interaction; Folate; Genomics; Intestinal absorption; Membrane transporter; Methotrexate; Proton coupled folate transporter; Sulfasalazine

Indexed keywords

2 OXOGLUTARIC ACID; 4 AMINOBENBENZOYLGLUTAMATE; 4 AMINOHIPPURIC ACID; 4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 METHYLTETRAHYDROFOLIC ACID; AMINOBENZOIC ACID DERIVATIVE; BROMSULFOPHTHALEIN; CARRIER PROTEIN; COCARBOXYLASE; DICLOFENAC; ESTRONE SULFATE; FOLIC ACID; FOLINATE; FUROSEMIDE; GLUTAMIC ACID; INDOMETACIN; LACTIC ACID; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; PROTON COUPLED FOLATE TRANSPORTER; SALAZOSULFAPYRIDINE; SUCCINIC ACID; TAUROCHOLIC ACID; TETRAHYDROFOLIC ACID; THIAMINE PHOSPHATE; UNCLASSIFIED DRUG; URATE;

CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; DRUG INHIBITION; DRUG POTENCY; DRUG UPTAKE; FOLATE METABOLISM; HUMAN; INTESTINE ABSORPTION; MALABSORPTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; RISK FACTOR; SHORT SURVEY;

EID: 65949084485     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21515     Document Type: Short Survey

References (34)

1. Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, Khan Y, Warley A, McCann FE, Hider RC, Frazer DM, Anderson GJ, Vulpe CD, Simpson RJ, McKie AT. 2005. Identification of an intestinal heme transporter. Cell 122:789-801. (Pubitemid 41242642)
2. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, Zhao R, Akabas MH, Goldman ID. 2006. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127:917-928.
3. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta K, Otagiri M, Hayashi Y, Yuasa H. 2007. Functional characterization of human PCFT/HCP1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther 322:469-476.
4. Dixon KH, Lanpher BC, Chiu J, Kelley K, Cowan KH. 1994. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem 269:17-20. (Pubitemid 24026611)
5. Williams FM, Murray RC, Underhill TM, Flintoff WF. 1994. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem 269:5810-5816. (Pubitemid 24242956)
6. Chiao JH, Roy K, Tolner B, Yang CH, Sirotnak FM. 1997. RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 272:11165-11170. (Pubitemid 27184111)
7. Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. 1997. Human intestinal folate transport: Cloning, expression, and distribution of complementary RNA. Gastroenterology 112:783-791.
8. Said HM, Nguyen TT, Dyer DL, Cowan KH, Rubin SA. 1996. Intestinal folate transport: Identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA. Biochim Biophys Acta 1281:164-172.
9. Qiu A, Min SH, Jansen M, Malhotra U, Tsai E, Cabelof DC, Matherly LH, Zhao R, Akabas MH, Goldman ID. 2007. Rodent intestinal folate transporters (SLC46A1): Secondary structure, functional properties, and response to dietary folate restriction. Am J Physiol Cell Physiol 293:C1669-C1678.
10. Inoue K, Nakai Y, Ueda S, Kamigaso S, Ohta K, Hatakeyama M, Hayashi Y, Otagiri M, Yuasa H. 2008. Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model. Am J Physiol Gastrointest Liver Physiol 294:G660-G668.
11. Umapathy NS, Gnana-Prakasam JP, Martin PM, Mysona B, Dun Y, Smith SB, Ganapathy V, Prasad PD. 2007. Cloning and functional characterization of the proton-coupled electrogenic folate transporter and analysis of its expression in retinal cell types. Invest Ophthalmol Vis Sci 48:5299-5305.
12. Zhao R, Gao F, Wang Y, Diaz GA, Gelb BD, Goldman ID. 2001. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem 276:1114-1118.
13. Zhao R, Gao F, Goldman ID. 2002. Reduced folate carrier transports thiamine monophosphate: An alternative route for thiamine delivery into mammalian cells. Am J Physiol Cell Physiol 282:C1512-C1517.
14. Sirotnak FM, Tolner B. 1999. Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19:91-122.
15. Steinberg SE. 1984. Mechanisms of folate homeostasis. Am J Physiol Gastrointest Liver Physiol 246:G319-G324.
16. Seyoum E, Selhub J. 1998. Properties of food folates determined by stability and susceptibility to intestinal pteroylpolyglutamate hydrolase action. J Nutr 128:1956-1960.
17. Said HM, Ghishan FK, Redha R. 1987. Folate transport by human intestinal brush-border membrane vesicles. Am J Physiol Gastrointest Liver Physiol 252:G229-G236.
18. Wollack JB, Makori B, Ahlawat S, Koneru R, Picinich SC, Smith A, Goldman ID, Qiu A, Cole PD, Glod J, Kamen B. 2008. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem 104:1494-1503.
19. Zhao R, Goldman ID. 2007. The molecular identity and characterization of a proton-coupled folate transporter - PCFT: Biological ramifications and impact on the activity of pemetrexed. Cancer Metastasis Rev 26:129-139.
20. Hepner GW, Booth CC, Cowan J, Hoffbrand AV, Mollin DL. 1968. Absorption of crystalline folic acid in man. Lancet 11:302-306.
21. Yuasa H, Miyamoto Y, Iga T, Hanano M, Watanabe J. 1987. Variation in D-glucose uptake along the intestinal tract. J Pharmacobio-Dyn 10:452-455.
22. Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD. 2003. Transport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: Effects of acquired mutations at R482 on methotrexate transport. Cancer Res 63:4048-4054.
23. Enokizono J, Kusuhara H, Sugiyama Y. 2007. Regional expression and activity of breast cancer resistance protein (bcrp/abcg2) in mouse intestine: Overlapping distribution with sulfotransferases. Drug Metab Dispos 35:922-928.
24. Sugimoto Y, Tsukahara S, Imai Y, Sugimoto Y, Ueda K, Tsuruo T. 2003. Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol Cancer Ther 2:105-112.
25. Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, Sugiyama Y. 2005. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059-1067.
26. Hooijberg JH, Broxterman HJ, Kool M, Assaraf YG, Peters GJ, Noordhuis P, Scheper RJ, Borst P, Pinedo HM, Jansen G. 1999. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59:2532-2535.
27. Subramanian VS, Marchant JS, Said HM. 2008. Apical membrane targeting and trafficking of the human proton-coupled transporter in polarized epithelia. Am J Physiol Cell Physiol 294:C233-C240.
28. Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, Malatack JJ, Rosenblatt DS, Goldman ID. 2007. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood 110:1147-1152.
29. Klotz U. 1985. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 10:285-302.
30. Liang E, Proudfoot J, Yazdanian M. 2000. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers. Pharm Res 17:1168-1174.
31. Zaher H, Khan AA, Palandra J, Brayman TG, Yu L, Ware JA. 2006. Breast cancer resistance protein (bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse. Mol Pharm 3:55-61.
32. Haagsma CJ, van Riel PL, de Jong AJ, van de Putte LB. 1997. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 36:1082-1088.
33. Haagsma CJ, Blom HJ, van Riel PL, van't Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, van de Putte LB. 1999. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79-84.
34. Halsted CH, Gandhi G, Tamura T. 1981. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med 305:1513-1517.